loading…
Q9991 Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg
BackQ9001Assessment by chaplain services→Q9002Counseling, individual, by chaplain services→Q9003Counseling, group, by chaplain services→Q9004Department of veterans affairs whole health partner services→Q9950Injection, sulfur hexafluoride lipid microspheres, per ml→Q9951Low osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml→Q9953Injection, iron-based magnetic resonance contrast agent, per ml→Q9954Oral magnetic resonance contrast agent, per 100 ml→Q9955Injection, perflexane lipid microspheres, per ml→Q9956Injection, octafluoropropane microspheres, per ml→Q9957Injection, perflutren lipid microspheres, per ml→Q9958High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml→Q9959High osmolar contrast material, 150-199 mg/ml iodine concentration, per ml→Q9960High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml→Q9961High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml→Q9962High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml→Q9963High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml→Q9964High osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml→Q9965Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml→Q9966Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml→Q9967Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml→Q9968Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg→Q9982Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries→Q9983Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries→Q9991Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg→Q9992Injection, buprenorphine extended-release (sublocade), greater than 100 mg→Q9996Injection, ustekinumab-ttwe (pyzchiva), subcutaneous, 1 mg→Q9997Injection, ustekinumab-ttwe (pyzchiva), intravenous, 1 mg→Q9998Injection, ustekinumab-aekn (selarsdi), biosimilar, 1 mg→Q9999Injection, ustekinumab-aauz (otulfi), biosimilar, 1 mg→
Procedure codeCODABLE
Q9991
Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg
- Part
- HCPCS Level II
- Q
- Temporary Codes
- Q9
- Q9001–Q9999
Source
CMS — ICD-10-PCS FY2026, HCPCS Level II october 2026, Procedure Codes 2026.